MLchartDataset catalogue

DCEP regimen

Term · Oncology and biomedicine · MLC-T-ONC-012937

A regimen consisting of dexamethasone, cyclophosphamide, etoposide, and cisplatin that may be used as a salvage regimen for relapsed and/or refractory plasma cell myeloma and/or as a mobilization regimen, followed by granulocyte colony-stimulating factor (G-CSF), for peripheral blood stem cell (PBSC) collection in plasma cell myeloma.

Table 1. Record
IdentifierMLC-T-ONC-012937
FieldOncology and biomedicine
AbbreviationDCEP
Synonymsdexamethasone-cyclophosphamide-etoposide-cisplatin; dexamethasone-Cytoxan-Vepesid-Platinol; dexamethasone/cyclophosphamide/etoposide/cisplatin; dexamethasone/cyclophosphamide/etoposide/cisplatin regimen
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012937",
  "term": "DCEP regimen",
  "field": "Oncology and biomedicine",
  "definition": "A regimen consisting of dexamethasone, cyclophosphamide, etoposide, and cisplatin that may be used as a salvage regimen for relapsed and/or refractory plasma cell myeloma and/or as a mobilization regimen, followed by granulocyte colony-stimulating factor (G-CSF), for peripheral blood stem cell (PBSC) collection in plasma cell myeloma.",
  "abbreviation": "DCEP",
  "synonyms": [
    "dexamethasone-cyclophosphamide-etoposide-cisplatin",
    "dexamethasone-Cytoxan-Vepesid-Platinol",
    "dexamethasone/cyclophosphamide/etoposide/cisplatin",
    "dexamethasone/cyclophosphamide/etoposide/cisplatin regimen"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/dcep-regimen/"
}

Record 5,729 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.